The Effect of Training Given by Whatsapp Application on Mamography Health Beliefs and Behaviors

NCT06238453 | Not Yet Recruiting

• 1 other identifier: B.30.2.ATA.0.01.00/681
• Study Type: observational
• Target: 134
• Locations: 0 countries
• Sites: N/A

Brief Summary

It is known that the healing process of breast cancer is accelerated thanks to the early diagnosis and effective treatment. Mammography screening is an important diagnostic method in the early diagnosis of breast cancer. It is thought that the education to be given according to the Health Belief Model will make important contributions to developing a positive attitude in breast cancer screenings and regular mammography.

Conditions

Breast Cancer

Keywords

Breast Cancer; Health Belief Model; Mammography

Outcome Measures

Primary Outcomes (2)

• Pre-test evaluation

  The Health Belief Model Scale for Breast Cancer Screening and the Mammography Self-Efficacy Scale will be administered to all women in the experimental and control groups for pre-test purposes. There is no overall total score of the Health Belief Model Scale on Breast Cancer Screenings. Each sub-dimension's own total score is evaluated. The scale is a Likert type scale scored from 1 to 5. The scoring of the scale ranges from 1 point for "strongly disagree" to 5 points for "strongly agree". Increasing scores obtained from sub-dimensions indicate that the perception of that sub-dimension is high. Mammography Self-Efficacy Scale has ten items and five-point Likert type. The scale answers "strongly disagree" are evaluated as 1 point, "disagree" as 2 points, "undecided" as 3 points, "agree" as 4 points and "strongly agree" as 5 points. A higher score for each dimension indicates a higher probability of having a mammogram.

  Three month

• Posttest evaluation

  Training presentations will be sent to the experimental group in the first 6 weeks and training videos will be sent in the last 2 weeks. A total of 8 weeks of intervention will be implemented. Training content will be sent via WhatsApp application once a week. No intervention will be made to the control group by the researchers during this period. Those in the control group will be invited to KETEM to have a mammogram. Three months after the training is completed, the Health Belief Model Scale for Breast Cancer Screening and the Mammography Self-Efficacy Scale will be administered to both groups for posttest purposes.

  Six month

Study Arms (2)

Experimental group

Educational content will be sent to the experimental group once a week via the WhatsApp application, and individual counseling will be provided by answering their questions at the same time. A total of 8 weeks of intervention will be implemented, training will be given with training presentations in the first 6 weeks and training videos will be sent in the last 2 weeks.

Control group

The control group will be invited to KETEM to have a mammogram without any intervention.

Eligibility Criteria

• Age: 40 Years - 69 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The population of the study will consist of women who have applied to Erzurum Cancer Early Diagnosis, Screening and Training Center before, had mammography and phone records, whose appointment has been made since December 2022, and who meet the sampling selection criteria.

You may qualify if:

• Be between the ages of 40-69,
• Be woman,
• Not having been diagnosed with breast cancer,
• Not to be pregnant, lactating or puerperal,
• Absence of a mental illness
• At least 2 years have passed since the last mammogram,
• Being able to use the WhatsApp application

You may not qualify if:

• Having had problems with breast cancer before,
• Having a mammogram at regular intervals,
• Having had breast-conserving surgery for any purpose.

Sponsors & Collaborators

• Kemal Yaran: lead

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Academician (Lecturer)

Study Record Dates

• First Submitted: December 29, 2023
• First Posted: February 2, 2024
• Study Start: February 12, 2024
• Primary Completion: April 2, 2024
• Study Completion: August 10, 2024
• Last Updated: February 2, 2024

Record last verified: 2024-02